Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise Williams

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Diabetes|June 25, 2010
Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalitiesOscar Rubio-Cabezas, Jayne A L Minton, Iren Kantor, et al.
Andrology|April 29, 2025
Gonadal function in males with WFS1 spectrum disorder (Wolfram syndrome)-A European cohort perspectiveJulia Rohayem, Olivia Cunningham, Denise Williams, et al.
Dimensions of Critical Care Nursing : DCCN|August 5, 2017
Use of a Virtual Learning Platform for Distance-Based Simulation in an Acute Care Nurse Practitioner CurriculumMargaret Carman, Shu Xu, Sharron Rushton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
A method for reducing ovarian doses in whole neuro-axis irradiation for medulloblastomaSusan V Harden, Nicola Twyman, David J Lomas, et al.
Current Medical Research and Opinion|October 22, 2005
Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemiaShelby D Reed, Jasmina I Radeva, Davey B Daniel, et al.
Blood|October 25, 2007
Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup studyMarie-Cécile Le Deley, Alfred Reiter, Denise Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapyBassem I Razzouk, Jeffrey D Hord, Marilyn Hockenberry, et al.
Genetics Research|December 10, 2019
Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics LaboratoryFiona S Togneri, Mark D Kilby, Elizabeth Young, et al.
Current Medical Research and Opinion|July 13, 2006
Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemiaDavid H Henry, Lucio N Gordan, Veena Charu, et al.
Prenatal Diagnosis|February 11, 2020
Evolution of a prenatal genetic clinic-A 10-year cohort studyFionnuala Mone, Clare O'Connor, Susan Hamilton, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Diabetes|June 25, 2010
Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalitiesOscar Rubio-Cabezas, Jayne A L Minton, Iren Kantor, et al.
Andrology|April 29, 2025
Gonadal function in males with WFS1 spectrum disorder (Wolfram syndrome)-A European cohort perspectiveJulia Rohayem, Olivia Cunningham, Denise Williams, et al.
Dimensions of Critical Care Nursing : DCCN|August 5, 2017
Use of a Virtual Learning Platform for Distance-Based Simulation in an Acute Care Nurse Practitioner CurriculumMargaret Carman, Shu Xu, Sharron Rushton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
A method for reducing ovarian doses in whole neuro-axis irradiation for medulloblastomaSusan V Harden, Nicola Twyman, David J Lomas, et al.
Current Medical Research and Opinion|October 22, 2005
Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemiaShelby D Reed, Jasmina I Radeva, Davey B Daniel, et al.
Blood|October 25, 2007
Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup studyMarie-Cécile Le Deley, Alfred Reiter, Denise Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapyBassem I Razzouk, Jeffrey D Hord, Marilyn Hockenberry, et al.
Genetics Research|December 10, 2019
Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics LaboratoryFiona S Togneri, Mark D Kilby, Elizabeth Young, et al.
Current Medical Research and Opinion|July 13, 2006
Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemiaDavid H Henry, Lucio N Gordan, Veena Charu, et al.
Prenatal Diagnosis|February 11, 2020
Evolution of a prenatal genetic clinic-A 10-year cohort studyFionnuala Mone, Clare O'Connor, Susan Hamilton, et al.
Pageof 10